Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 2,575 GBp
Change Today +26.00 / 1.02%
Volume 314.2K
ITRK On Other Exchanges
As of 11:35 AM 10/9/15 All times are local (Market data is delayed by at least 15 minutes).

intertek group plc (ITRK) Snapshot

2,562 GBp
Previous Close
2,549 GBp
Day High
2,600 GBp
Day Low
2,555 GBp
52 Week High
11/11/14 - 2,797 GBp
52 Week Low
12/15/14 - 2,141 GBp
Market Cap
Average Volume 10 Days
1.18 GBp
Shares Outstanding
55.67 GBp
Dividend Yield
Current Stock Chart for INTERTEK GROUP PLC (ITRK)

Related News

No related news articles were found.

intertek group plc (ITRK) Related Businessweek News

No Related Businessweek News Found

intertek group plc (ITRK) Details

Intertek Group plc provides quality and safety solutions to various industries worldwide. The company operates in five divisions: Industry & Assurance, Commodities, Consumer Goods, Commercial & Electrical, and Chemicals & Pharmaceuticals. The Industry & Assurance division offers services, such as asset integrity management, exploration and production support, consulting, training, and third-party management systems auditing services; and certification, second-party supplier auditing, sustainability data verification, and process performance analysis services. This division serves oil, gas, nuclear, power, renewable energy, construction, food, chemical, and agricultural industries. The Commodities division provides independent cargo inspection, analytical assessment, calibration, and related research and technical services to the petroleum, mining, minerals, and biofuels industries, as well as to governments and regulatory bodies to support trade activities that enable the flow of goods across borders. The Consumer Goods division offers testing, inspection, auditing, advisory, quality assurance, and hazardous substance testing services to the retailers, manufacturers, and distributors in textiles, toys, footwear, hardlines, food, and retail industries. The Commercial & Electrical division provides safety and performance testing, certification, and consulting services to manufacturers and retailers in home appliances, consumer electronics, heating, ventilation, air conditioning, and refrigeration industries. The Chemicals & Pharmaceuticals division offers laboratory measurement and technical support services to various industries, including chemical, pharmaceutical, oil and gas, and automotive and aerospace industries. It was formerly known as Intertek Testing Services plc and changed its name to Intertek Group plc in August 2005. Intertek Group plc was founded in 1885 and is headquartered in London, United Kingdom.

38,000 Employees
Last Reported Date: 08/3/15
Founded in 1885

intertek group plc (ITRK) Top Compensated Officers

Chief Financial Officer and Director
Total Annual Compensation: 159.0K GBP
Compensation as of Fiscal Year 2014.

intertek group plc (ITRK) Key Developments

Intertek Launches New Service for Mobile Health Applications

Intertek Group plc has launched the 6-Point Security check, a new service for mobile health applications that assesses the cybersecurity of browser-based applications, mobile or embedded applications with a cloud backend and cloud architecture. The security check is designed to identify deficiencies and vulnerabilities and to develop recommendations for correcting issues discovered during the assessment. Data security and patient privacy are top priorities for the medical device industry and many manufacturers have questions about testing requirements and regulations in the US market. Intertek's 6-Point Security Check will evaluate new software, applications and connected devices to fulfill Food and Drug Administration (FDA) requirements for demonstrated cybersecurity risk management measures. The 6-Point Security check consists of: scans according to Open Web Application Security Project (OWASP) recommendations; review of web services configuration; review of data security logs; identification of potential Structured Query Language (SQL) injection points; validation of security controls; and recommendations for risk mitigation. The new offering was developed in conjunction with an Intertek white paper identifying strategies for stronger mobile health application security to simplify FDA recommendations. Key areas highlighted in the white paper include network scanning, password protection, malware detection and privacy protection.

Intertek Wins Third Party Inspection Procurement Contract for the South Oil Company in Iraq

Intertek has won a third party inspection procurement contract for the South Oil Company in Iraq. The multi-year agreement is the first time SOC has appointed a third party inspection company to help ensure the quality and safety of all their projects, which are contracted to various oil and gas companies. Intertek's scope of work will include conducting inspections of components and materials used by SOC-managed oil and gas companies. Intertek's network of experienced staff will verify the quality of products and processes throughout the supply chain; from the sourcing of materials through to the manufacturing and fabrication of products. Some of the technical inspection services will take place at the factories to oversee the way the production process is piloted and to ensure it complies with international standards and adhere to the specifications set by the client. Other inspections and testing will be conducted in Intertek laboratories across the world.

Intertek Opens New Biologic Medicine Contract Services Laboratory in Manchester, UK

Intertek opened a 10,000 ft² bioanalytical and biopharmaceutical characterisation facility to deliver world-class scientific services to support the growing pipeline of biologics medicines such as monoclonal antibodies currently in development by clients around the globe. This facility brings expanded capacity to create 30,000 ft2 of analytical and bioanalytical laboratories at Intertek’s Manchester-based Centre of Excellence for Biologics. The new bioanalysis, immunogenicity and characterisation capability will help drug companies to ensure that biologics medicines such as monoclonal antibodies (mAbs), recombinant proteins and vaccines are safe and effective to treat heart disease, cancer-related diseases such as leukemia or melanoma and other chronic ailments.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ITRK:LN 2,575.00 GBp +26.00

ITRK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Amec Foster Wheeler PLC 829.00 GBp +22.50
Babcock International Group PLC 983.00 GBp +31.00
Core Laboratories NV $119.07 USD +0.81
Eurofins Scientific SE €274.90 EUR -0.75
WS Atkins PLC 1,392 GBp +12.00
View Industry Companies

Industry Analysis


Industry Average

Valuation ITRK Industry Range
Price/Earnings 21.3x
Price/Sales 1.9x
Price/Book 5.1x
Price/Cash Flow 15.2x
TEV/Sales 1.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INTERTEK GROUP PLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at